Derleme
BibTex RIS Kaynak Göster

Yıl 2020, Cilt: 23 Sayı: 3, 240 - 247, 05.10.2020

Mohamed Faızal Asan , G Subhas Babu , Renita Castelino , Kumuda Rao , Vaıbhav Pandıta

https://doi.org/10.7126/cumudj.731774
Cited By: 2

Öz

Kaynakça

  • 1. Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology 2018;23(2):130-137.
  • 2. Tyrrell DA, Bynoe ML. Cultivation of viruses from a high proportion of patients withcolds. Lancet 1966:76-77 . 3. Hamre D, Procknow JJ. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 1966(1):190-193.
  • 4. McIntosh K, Becker WB, Chanock RM. Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease. Proc Natl Acad Sci U S A 1967;58(6):2268–2273.
  • 5. Witte KH, Tajima M, Easterday BC. Morphologic characteristics and nucleic acid type of transmissible gastroenteritis virus of pigs. Arch Gesamte Virusforsch 1968;23(1-2):53-70.
  • 6. Tyrrell DA, Almeida JD, Cunningham CH, Dowdle WR, Hofstad MS, McIntosh K.Coronaviridae. Intervirology 1975;5(1-2):76-82.
  • 7. Drosten C, Günther S, Preiser W, Van Der Werf S, Brodt HR, Becker S, et al.Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348(20):1967-76.
  • 8. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003;302(5643):276-278.
  • 9. Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of anovel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367(19):1814-20.
  • 10. Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM, et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 2014;370(26):2499-505.
  • 11. de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, et al. Commentary: Middle East respiratory syndrome coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. J Virol 2013;87(14):7790-2.
  • 12. World Health Organization. Novel coronavirus - China. Available from: http://www.who.int/csr/zxcvXDdon/12 -january-2020-novel-coronavirus-china/en/, accessed on March 25, 2020.
  • 13. WHO. Clinical management of severe acute respiratory infection when Novel coronavirus(nCoV) infection is suspected: Interim Guidance. Available from: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory infection-when-novel-coronavirus-(ncov)-infection-is-suspected, accessed on March 20, 2020.
  • 14. Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 2015;1282:1–23.
  • 15. Xu X, Chen P, Wang J, Feng J, Zhou H, Li X. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 2020;63(3):457-60.
  • 16. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395(10224):565-74.
  • 17. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol 2020;94(7):127-20.
  • 18. Parr J. Pneumonia in China: lack of information raises concerns among Hong Kong health workers. BMJ 2020;368:m56.
  • 19. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. Nature 2020;579(7798):270–273.
  • 20. Centers for Disease Control and Prevention. How 2019-nCoV Spreads. Available from: https://www.cdc.gov/coronavirus/2019ncov/about/transmission.html, accessed on March 20, 2020.
  • 21. World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report - 90. Available from : https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200419-sitrep-90-covid-19.pdf?sfvrsn=551d47fd_2, accessed on April 20, 2020.
  • 22. Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P.Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spikeglycoprotein-mediated viral entry. Proc Natl Acad Sci U S A 2004;101(12):4240-5.
  • 23. Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G. SARS coronavirus entry into hostcells through a novel clathrin-and caveolae-independent endocytic pathway. Cell Res 2008;18(2):290-301.
  • 24. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506.
  • 25. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017;39(5):529–539.
  • 26. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8(4):420-2.
  • 27. World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report - 49. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200309-sitrep-49-covid-19.pdf?sfvrsn=70dabe61_4, accessed on March 10, 2020.
  • 28. Centers for Disease Control and Prevention. Symptoms. Available from : https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html, accessed on March 10, 2020.
  • 29. World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus2019/technical-guidance/naming-the-coronavirus-disease- (covid -2019)-and -the-virus-that-causes-it, accessed on March 25, 2020
  • 30. World Health Organization. Coronavirus Disease 2019. Available from: https://www.who.int/emergencies/diseases/novel coronavirus-2019, accessed on March 15, 2020.
  • 31. World Health Organization. Laboratory testing for Middle East Respiratory Syndrome Coronavirus: Interim guidance. Available from: http://www.who.int/csr/disease/coronavirus_infections/merslaboratory-testing/en/, accessed on March 20, 2020.
  • 32. To KK, Tsang OT, Yip CC, Chan KH, Wu TC, Chan JM, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis 2020;ciaa149.
  • 33. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30(3):269-71.
  • 34. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparentefficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020;14(1):72–73.
  • 35. Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A.New insights into the antiviral effects of chloroquine. Lancet Infect Dis 2006;6(2):67-9.
  • 36. Rajput R, Chouhan Z, Suthar P, et al. MERS-CoV (middle east respiratory syndrome corona virus): a dental surgeon perspective. International Journal of Contemporary Medical Research 2015; 2(5): 1228 – 30.
  • 37. World Health Organization. Global Surveillance for human infection with novel coronavirus (2019 nCoV).Interim guidance.2020. Available from : https://www.who.int/publications-detail/globalsurveillancefor-human-infection-with-novel-coronavirus-(2019-ncov), accessed on March 10, 2020.
  • 38. Ministry of Health & Family Welfare, Government of India. Guidance on Surveillance for human infection with 2019-nCoV.Available from : https://mohfw.gov.in/sites/default/files/Guidance%20document%20-%202019-nCoV.pdf , accessed on March 10, 2020.
  • 39. Indian Dental Association. Recommendations for Dental professionals on the Coronavirus threat. Available from: https://www.ida.org.in/pdf/IDA_Recommendations_for_Dental_Professionals_on_the_Coronavirus_Thr eat.pdf, accessed on 10 April, 2020.
  • 40. Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV andcontrols in dental practice. Int J Oral Sci 2020;12(1):1-6.
  • 41. American Dental Association. What constitutes a dental emergency ? Available from: https://success.ada.org/~/media/CPS/Files/Open%20Files/ADA_COVID19_Dental_Emergency_DDS.pdf?_ga=2.19769083.2128206694.1585904752-319377604.1584360161, accessed on 10 April, 2020.
  • 42. Meng L, Hua F, Bian Z. Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine. J Dent Res 2020; 22034520914246. Epub 2020 Mar 12.
  • 43. Dave M, Seoudi N, Coulthard P. Urgent dental care for patients during the COVID-19 pandemic. Lancet 2020;S0140-6736(20)30806-0. Epub 2020 Apr 3.
  • 44. Ather A, Patel B, Ruparel N, Diogenes A, Hargreaves K. Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care. J Endod 2020;S0099-2399(20)30159-X. Epub 2020 Apr 6.

COVID-19 PANDEMIC – A REVIEW WITH A DENTAL PERSPECTIVE

Yıl 2020, Cilt: 23 Sayı: 3, 240 - 247, 05.10.2020

Mohamed Faızal Asan , G Subhas Babu , Renita Castelino , Kumuda Rao , Vaıbhav Pandıta

https://doi.org/10.7126/cumudj.731774
Cited By: 2

Öz

Novel betacoronavirus is a recent threat to the global health. It has been identified as the cause of the outbreak of respiratory illness that originated in the city of Wuhan, China and has spread rapidly to several other countries within a short span of time. Transmission occurs through respiratory droplets or contaminated surfaces from an infected person, saliva of infected persons has also shown shedding of live virus. Clinical manifestations of COVID-19 can range from mild to severe and can even progress to ARDS and septic shock leading to death. All health care professionals including dental surgeons are at a high risk of acquiring the infection. Dental clinics and hospitals carry a high risk of cross-infection. Aggressive preventive and personal protective measures help in preventing exposure to the infection. Dental professionals should adopt various specific preventive methods and treatment strategies to prevent the spread of the infection in a dental setup.

Anahtar Kelimeler

Coronavirus Dental practice management Infection control Pandemic Pneumonia

Kaynakça

  • 1. Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology 2018;23(2):130-137.
  • 2. Tyrrell DA, Bynoe ML. Cultivation of viruses from a high proportion of patients withcolds. Lancet 1966:76-77 . 3. Hamre D, Procknow JJ. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 1966(1):190-193.
  • 4. McIntosh K, Becker WB, Chanock RM. Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease. Proc Natl Acad Sci U S A 1967;58(6):2268–2273.
  • 5. Witte KH, Tajima M, Easterday BC. Morphologic characteristics and nucleic acid type of transmissible gastroenteritis virus of pigs. Arch Gesamte Virusforsch 1968;23(1-2):53-70.
  • 6. Tyrrell DA, Almeida JD, Cunningham CH, Dowdle WR, Hofstad MS, McIntosh K.Coronaviridae. Intervirology 1975;5(1-2):76-82.
  • 7. Drosten C, Günther S, Preiser W, Van Der Werf S, Brodt HR, Becker S, et al.Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348(20):1967-76.
  • 8. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003;302(5643):276-278.
  • 9. Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of anovel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367(19):1814-20.
  • 10. Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM, et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 2014;370(26):2499-505.
  • 11. de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, et al. Commentary: Middle East respiratory syndrome coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. J Virol 2013;87(14):7790-2.
  • 12. World Health Organization. Novel coronavirus - China. Available from: http://www.who.int/csr/zxcvXDdon/12 -january-2020-novel-coronavirus-china/en/, accessed on March 25, 2020.
  • 13. WHO. Clinical management of severe acute respiratory infection when Novel coronavirus(nCoV) infection is suspected: Interim Guidance. Available from: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory infection-when-novel-coronavirus-(ncov)-infection-is-suspected, accessed on March 20, 2020.
  • 14. Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 2015;1282:1–23.
  • 15. Xu X, Chen P, Wang J, Feng J, Zhou H, Li X. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 2020;63(3):457-60.
  • 16. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395(10224):565-74.
  • 17. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol 2020;94(7):127-20.
  • 18. Parr J. Pneumonia in China: lack of information raises concerns among Hong Kong health workers. BMJ 2020;368:m56.
  • 19. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. Nature 2020;579(7798):270–273.
  • 20. Centers for Disease Control and Prevention. How 2019-nCoV Spreads. Available from: https://www.cdc.gov/coronavirus/2019ncov/about/transmission.html, accessed on March 20, 2020.
  • 21. World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report - 90. Available from : https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200419-sitrep-90-covid-19.pdf?sfvrsn=551d47fd_2, accessed on April 20, 2020.
  • 22. Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P.Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spikeglycoprotein-mediated viral entry. Proc Natl Acad Sci U S A 2004;101(12):4240-5.
  • 23. Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G. SARS coronavirus entry into hostcells through a novel clathrin-and caveolae-independent endocytic pathway. Cell Res 2008;18(2):290-301.
  • 24. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506.
  • 25. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017;39(5):529–539.
  • 26. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8(4):420-2.
  • 27. World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report - 49. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200309-sitrep-49-covid-19.pdf?sfvrsn=70dabe61_4, accessed on March 10, 2020.
  • 28. Centers for Disease Control and Prevention. Symptoms. Available from : https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html, accessed on March 10, 2020.
  • 29. World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus2019/technical-guidance/naming-the-coronavirus-disease- (covid -2019)-and -the-virus-that-causes-it, accessed on March 25, 2020
  • 30. World Health Organization. Coronavirus Disease 2019. Available from: https://www.who.int/emergencies/diseases/novel coronavirus-2019, accessed on March 15, 2020.
  • 31. World Health Organization. Laboratory testing for Middle East Respiratory Syndrome Coronavirus: Interim guidance. Available from: http://www.who.int/csr/disease/coronavirus_infections/merslaboratory-testing/en/, accessed on March 20, 2020.
  • 32. To KK, Tsang OT, Yip CC, Chan KH, Wu TC, Chan JM, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis 2020;ciaa149.
  • 33. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30(3):269-71.
  • 34. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparentefficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020;14(1):72–73.
  • 35. Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A.New insights into the antiviral effects of chloroquine. Lancet Infect Dis 2006;6(2):67-9.
  • 36. Rajput R, Chouhan Z, Suthar P, et al. MERS-CoV (middle east respiratory syndrome corona virus): a dental surgeon perspective. International Journal of Contemporary Medical Research 2015; 2(5): 1228 – 30.
  • 37. World Health Organization. Global Surveillance for human infection with novel coronavirus (2019 nCoV).Interim guidance.2020. Available from : https://www.who.int/publications-detail/globalsurveillancefor-human-infection-with-novel-coronavirus-(2019-ncov), accessed on March 10, 2020.
  • 38. Ministry of Health & Family Welfare, Government of India. Guidance on Surveillance for human infection with 2019-nCoV.Available from : https://mohfw.gov.in/sites/default/files/Guidance%20document%20-%202019-nCoV.pdf , accessed on March 10, 2020.
  • 39. Indian Dental Association. Recommendations for Dental professionals on the Coronavirus threat. Available from: https://www.ida.org.in/pdf/IDA_Recommendations_for_Dental_Professionals_on_the_Coronavirus_Thr eat.pdf, accessed on 10 April, 2020.
  • 40. Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV andcontrols in dental practice. Int J Oral Sci 2020;12(1):1-6.
  • 41. American Dental Association. What constitutes a dental emergency ? Available from: https://success.ada.org/~/media/CPS/Files/Open%20Files/ADA_COVID19_Dental_Emergency_DDS.pdf?_ga=2.19769083.2128206694.1585904752-319377604.1584360161, accessed on 10 April, 2020.
  • 42. Meng L, Hua F, Bian Z. Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine. J Dent Res 2020; 22034520914246. Epub 2020 Mar 12.
  • 43. Dave M, Seoudi N, Coulthard P. Urgent dental care for patients during the COVID-19 pandemic. Lancet 2020;S0140-6736(20)30806-0. Epub 2020 Apr 3.
  • 44. Ather A, Patel B, Ruparel N, Diogenes A, Hargreaves K. Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care. J Endod 2020;S0099-2399(20)30159-X. Epub 2020 Apr 6.
Toplam 43 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Review
Yazarlar

Mohamed Faızal Asan 0000-0001-9747-1914

G Subhas Babu 0000-0001-9383-7886

Renita Castelino 0000-0002-8696-549X

Kumuda Rao 0000-0002-6214-1381

Vaıbhav Pandıta 0000-0003-3163-5300

Yayımlanma Tarihi 5 Ekim 2020
Gönderilme Tarihi 4 Mayıs 2020
Yayımlandığı Sayı Yıl 2020Cilt: 23 Sayı: 3

Kaynak Göster

EndNote Faızal Asan M, Babu GS, Castelino R, Rao K, Pandıta V (01 Ekim 2020) COVID-19 PANDEMIC – A REVIEW WITH A DENTAL PERSPECTIVE. Cumhuriyet Dental Journal 23 3 240–247.

Cited By

Perception Towards the COVID-19 Vaccine Among the Paramedical Staffs
Acta Medica Bulgarica
https://doi.org/10.2478/amb-2024-0054
Evaluation of the effects of the COVID‐19 pandemic on dentistry
Clinical and Experimental Dental Research
https://doi.org/10.1002/cre2.466
 Kapak Resmi İndir

Cumhuriyet Dental Journal (Cumhuriyet Dent J, CDJ) is the official publication of Cumhuriyet University Faculty of Dentistry. CDJ is an international journal dedicated to the latest advancement of dentistry. The aim of this journal is to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in different areas of dentistry. First issue of the Journal of Cumhuriyet University Faculty of Dentistry was published in 1998. In 2010, journal's name was changed as Cumhuriyet Dental Journal. Journal’s publication language is English.


CDJ accepts articles in English. Submitting a paper to CDJ is free of charges. In addition, CDJ has not have article processing charges.

Frequency: Four times a year (March, June, September, and December)

IMPORTANT NOTICE

All users of Cumhuriyet Dental Journal should visit to their user's home page through the "https://dergipark.org.tr/tr/user" " or "https://dergipark.org.tr/en/user" links to update their incomplete information shown in blue or yellow warnings and update their e-mail addresses and information to the DergiPark system. Otherwise, the e-mails from the journal will not be seen or fall into the SPAM folder. Please fill in all missing part in the relevant field.

Please visit journal's AUTHOR GUIDELINE to see revised policy and submission rules to be held since 2020.